Emergent Biosolutions Inc (EBS)

Finanzdaten der Emergent Biosolutions Inc-Aktie (EBS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	50.10%234.30	156.10	148.70	231.10	140.90
Cost Of Revenue	34.86%97.10	72.00	84.90	85.90	66.90
	4.29%44.60	46.60	-	-	-
Selling, General, and Administrative	4.29%44.60	46.60	-	-	-
Research and Development	12.38%9.20	10.50	-	-	-
Operating Income/Loss	1,291%-125.10	10.50	-27.90	76.50	1.60
Nonoperating Income/Loss	1,521%-41.20	2.90	-22.80	-18.90	-18.40
Income/Loss From Continuing Operations Before Tax	1,341%-166.30	13.40	-50.70	57.60	-16.80
Income Tax Expense/Benefit	110.61%13.90	6.60	3.90	6.40	-4.80
	2,750%-180.20	6.80	-54.60	51.20	-12.00
Attributable To Parent	2,750%-180.20	6.80	-54.60	51.20	-12.00
Basic Average Shares	0.58%51.60	51.90	-0.40	53.20	54.20
Diluted Average Shares	8.67%51.60	56.50	-	56.50	54.20
Basic Earnings Per Share	2,785%-3.49	0.13	-1.01	0.96	-0.22
Diluted Earnings Per Share	5,086%-3.49	0.07	-0.96	0.91	-0.22